# Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite

> **NCT02570347** · PHASE4 · TERMINATED · sponsor: **Jawaharlal Institute of Postgraduate Medical Education & Research** · enrollment: 66 (actual)

## Conditions studied

- Snake Bites

## Interventions

- **DRUG:** Co-amoxiclav
- **BIOLOGICAL:** Tetanus toxoid

## Key facts

- **NCT ID:** NCT02570347
- **Lead sponsor:** Jawaharlal Institute of Postgraduate Medical Education & Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-03
- **Primary completion:** 2019-10-24
- **Final completion:** 2020-03-31
- **Target enrollment:** 66 (ACTUAL)
- **Why stopped:** Slower than anticipated recruitment and emergent COVID-19 situation
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570347, "Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02570347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*